#TITLE_ALTERNATIVE#
Silymarin is natural active compounds isolated from Silybum marianum plant. Traditionally, <br /> <br /> silymarin has been used as a herbal medicine for the treatment of liver-related disorders. <br /> <br /> However, silymarin has a low bioavailability due to its poor absor...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/31747 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Silymarin is natural active compounds isolated from Silybum marianum plant. Traditionally, <br />
<br />
silymarin has been used as a herbal medicine for the treatment of liver-related disorders. <br />
<br />
However, silymarin has a low bioavailability due to its poor absorption and rapid metabolism. This <br />
<br />
study was performed to develop nanoemulsion system containing silymarin to improve its <br />
<br />
bioavailability. The formulation was refered to the previous work. The oil phase of nanoemulsion <br />
<br />
consisted of castor oil, chremophor RH 40 as surfactant, and polyethylene glycol 400 as cosurfactant with a ratio of 1:8:1. The nanoemulsion was formed spontaneously by the addition of <br />
<br />
phosphat buffer at pH 6.4 under mild stirring. Characterization of nanoemulsion included visual <br />
<br />
appearance, droplet size, polydispersity index, zeta potential, entrapment efficiency, and physicalchemical stability under normal storage condition for 2 weeks. In addition, the characterization <br />
<br />
was also conducted in vitro using MCF-7 and MDA-MB cell lines to study the toxicity and cellular <br />
<br />
uptake capability. The toxicity assay to determine the IC50 value was done using MTS method [3- <br />
<br />
(4,5-dimethylthiazol-2-yl)-5-(3- carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]. <br />
<br />
Determination of IC50 was done using microplate reader on wavelength of 490 nm. Further, the <br />
<br />
interaction of sylimarin nanoemulsion and the solution on to MCF-7 cell line was analysed with <br />
<br />
confocal microscopy, after 3 and 6 hours incubation with concentration below IC50 value. When <br />
<br />
the confocal microscope was used to study the cellular uptake of the nanoemulsion, Carbon dot <br />
<br />
was applied and co-encapsulated with silymarin. Silymarin nanoemulsion has droplet size of 27.95 <br />
<br />
± 4.31 nm, PI 0.296 ± 0.09 and charge of <br />
<br />
-11.81mV; and the entrapment efficiency was 91.92 ± 0.04 %. Nanoemulsion containing silymarin <br />
<br />
and carbon quantum dots showed good stabilty under studied condition. Based on the stability <br />
<br />
data, the nanoemulsion showed no significant changes of the entrapment efficiency as well as the <br />
<br />
physical characteristic. The IC50 value of silymarin nanoemulsion and solution was respectively <br />
<br />
30.67 <br />
<br />
µg/mL and 45.40 µg/mL for MCF-7, 37.50 µg/mL and 39.14 µg/mL for MDA-MB. The <br />
<br />
nanoemulsion containing sylimarin is potential to penetrate into the MCF-7 cell line at <br />
<br />
concentration of 12.5 µg/mL both after 3 and 6 hours incubation. According to this study, the <br />
<br />
developed nanoemulsion is promising system to improve the therapeutic value of sylimarin. To <br />
<br />
confirm this conclusion, it is required further studies. <br />
|
---|